275 related articles for article (PubMed ID: 32334636)
1. Dual anti-platelet therapy following percutaneous coronary intervention in a population of patients with thrombocytopenia at baseline: a meta-analysis.
Long M; Ye Z; Zheng J; Chen W; Li L
BMC Pharmacol Toxicol; 2020 Apr; 21(1):31. PubMed ID: 32334636
[TBL] [Abstract][Full Text] [Related]
2. Duration of Dual Antiplatelet Therapy and Late Stent Thrombosis Following Percutaneous Coronary Intervention with Second-Generation Drug-Eluting Stents: A Simple Meta-Analysis of Randomized Controlled Trials.
Lin BY; Li P; Wu P; Jiang RN; Bundhun PK; Ahmed MA
Adv Ther; 2019 Nov; 36(11):3166-3173. PubMed ID: 31535329
[TBL] [Abstract][Full Text] [Related]
3. [Meta-analysis on safety and efficacy of dual antiplatelet therapy combining with proton pump inhibitors for patients after percutaneous coronary intervention].
Che QQ; Wu Q; Liang YB; Sun RM; Lyu QW; Ma JL; Hu H; Lin X; Xu GL; Sun SG; Zhang C; Wang QY; Yu J; Bai F
Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Feb; 47(2):129-140. PubMed ID: 30818941
[No Abstract] [Full Text] [Related]
4. Guided versus standard antiplatelet therapy in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis.
Galli M; Benenati S; Capodanno D; Franchi F; Rollini F; D'Amario D; Porto I; Angiolillo DJ
Lancet; 2021 Apr; 397(10283):1470-1483. PubMed ID: 33865495
[TBL] [Abstract][Full Text] [Related]
5. Risk of Stroke vs. Intracerebral Hemorrhage in Patients with Non-Valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Comparing Dual vs. Triple Antithrombotic Therapy.
Desai A; Escamilla-Ocanas C; Dilip D; Saber H; Damani R
J Stroke Cerebrovasc Dis; 2021 Apr; 30(4):105654. PubMed ID: 33578352
[TBL] [Abstract][Full Text] [Related]
6. Post percutaneous coronary interventional adverse cardiovascular outcomes and bleeding events observed with prasugrel versus clopidogrel: direct comparison through a meta-analysis.
Bundhun PK; Huang F
BMC Cardiovasc Disord; 2018 May; 18(1):78. PubMed ID: 29720092
[TBL] [Abstract][Full Text] [Related]
7. Should a prolonged duration of dual anti-platelet therapy be recommended to patients with diabetes mellitus following percutaneous coronary intervention? A systematic review and meta-analysis of 15 studies.
Bundhun PK; Yanamala CM; Huang F
BMC Cardiovasc Disord; 2016 Aug; 16(1):161. PubMed ID: 27577530
[TBL] [Abstract][Full Text] [Related]
8. Short dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk patients: Systematic review and meta-analysis.
Bainey KR; Marquis-Gravel G; MacDonald BJ; Bewick D; Yan A; Turgeon RD
PLoS One; 2023; 18(9):e0291061. PubMed ID: 37656721
[TBL] [Abstract][Full Text] [Related]
9. Adverse clinical outcomes associated with double dose clopidogrel compared to the other antiplatelet regimens in patients with coronary artery disease: a systematic review and meta-analysis.
Zhuo X; Zhuo B; Ouyang S; Niu P; Xiao M
BMC Pharmacol Toxicol; 2018 Sep; 19(1):54. PubMed ID: 30176938
[TBL] [Abstract][Full Text] [Related]
10. Dual therapy with an oral non-vitamin K antagonist and a P2Y12 inhibitor vs triple therapy with aspirin, a P2Y12 inhibitor and a vitamin K antagonist for the treatment of diabetes mellitus patients with co-existing atrial fibrillation following percutaneous coronary intervention: A meta-analysis.
Wang Q; Yang K
Medicine (Baltimore); 2021 Apr; 100(15):e25546. PubMed ID: 33847681
[TBL] [Abstract][Full Text] [Related]
11. Comparing the clinical outcomes in patients with atrial fibrillation receiving dual antiplatelet therapy and patients receiving an addition of an anticoagulant after coronary stent implantation: A systematic review and meta-analysis of observational studies.
Chaudhary N; Bundhun PK; Yan H
Medicine (Baltimore); 2016 Dec; 95(50):e5581. PubMed ID: 27977592
[TBL] [Abstract][Full Text] [Related]
12. Platelet reactivity-adjusted antiplatelet therapy in patients with percutaneous coronary intervention: a meta-analysis of randomized controlled trials.
Xing Z; Tang L; Zhu Z; Huang J; Peng X; Hu X
Platelets; 2018 Sep; 29(6):589-595. PubMed ID: 28895771
[TBL] [Abstract][Full Text] [Related]
13. P2Y12 Inhibitor Monotherapy After a Short Dual Antiplatelet Therapy Versus Standard-Term Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention: A Contemporary Meta-Analysis.
Ho AC; Egolum U; Parker S; Dimmel J; Hawkins A; Ling H
Clin Drug Investig; 2020 Sep; 40(9):799-808. PubMed ID: 32661914
[TBL] [Abstract][Full Text] [Related]
14. The optimal discontinuation of dual antiplatelet therapy in patients undergoing percutaneous coronary intervention with drug-eluting stents: A meta-analysis of randomized trials.
Wang W; Liu J; Fang J; Liu Y; An T; Zou M; Cheng G
Int J Cardiol; 2017 May; 235():73-86. PubMed ID: 28284499
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of short-term 1-3 months versus standard 12 months dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: a meta-analysis of randomized clinical trials.
Zhang WJ; Qiao X; Liang XY; Li Y; Yang RR; Wang ZL
Platelets; 2021 Jul; 32(5):582-590. PubMed ID: 32627616
[TBL] [Abstract][Full Text] [Related]
16. Clinical Usefulness of PRECISE-DAPT Score for Predicting Bleeding Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: An Analysis From the SMART-DATE Randomized Trial.
Choi KH; Song YB; Lee JM; Park TK; Yang JH; Choi JH; Choi SH; Oh JH; Cho DK; Lee JB; Doh JH; Kim SH; Jeong JO; Bae JH; Kim BO; Cho JH; Suh IW; Kim DI; Park HK; Park JS; Choi WG; Lee WS; Gwon HC; Hahn JY
Circ Cardiovasc Interv; 2020 May; 13(5):e008530. PubMed ID: 32354228
[TBL] [Abstract][Full Text] [Related]
17. Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI: The STOPDAPT-2 Randomized Clinical Trial.
Watanabe H; Domei T; Morimoto T; Natsuaki M; Shiomi H; Toyota T; Ohya M; Suwa S; Takagi K; Nanasato M; Hata Y; Yagi M; Suematsu N; Yokomatsu T; Takamisawa I; Doi M; Noda T; Okayama H; Seino Y; Tada T; Sakamoto H; Hibi K; Abe M; Kawai K; Nakao K; Ando K; Tanabe K; Ikari Y; Hanaoka KI; Morino Y; Kozuma K; Kadota K; Furukawa Y; Nakagawa Y; Kimura T;
JAMA; 2019 Jun; 321(24):2414-2427. PubMed ID: 31237644
[TBL] [Abstract][Full Text] [Related]
18. Short- versus standard-term dual antiplatelet therapy after percutaneous coronary intervention with drug-eluting stent implantation: A meta-analysis.
Basaraba JE; Barry AR
J Cardiol; 2017 Jan; 69(1):353-358. PubMed ID: 27590413
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of single vs dual antiplatelet therapy in patients on anticoagulation undergoing percutaneous coronary intervention: A systematic review and meta-analysis.
Atti V; Turagam MK; Garg J; Velagapudi P; Patel NJ; Basir MB; Mujer MT; Rayamajhi S; Abela GS; Koerber S; Gopinnathanair R; Lakkireddy D
J Cardiovasc Electrophysiol; 2019 Nov; 30(11):2460-2472. PubMed ID: 31432607
[TBL] [Abstract][Full Text] [Related]
20. P2Y
Jin Y; Huang H; Shu X; Chen S; Lu L; Gao X; Wu Z
Thromb Res; 2021 Feb; 198():115-121. PubMed ID: 33316640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
